KM-plot analysis manifested that high ANXA2P2 expression was relevant to adverse PFI in seven cancers, containing HNSC (Figure 3B), LGG (Figure 3C), LIHC (Figure 3D), MESO (Figure 3E), PAAD (Figure 3F), OV (Figure 3G), USC (Figure 3H), and UVM (Figure 3I). This evidence concerns the gene ANXA2P2 and cancer.